Study guide
8.3 Chronic Kidney Disease, Dialysis & Transplant
Board Certified Specialist in Pediatric Nutrition CSP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 CSP Exam Facts, Format & Fees 1.2 Eligibility & Application Process 1.3 Scoring, Test Day Logistics & Study Strategy
2 Pediatric Growth & Development
2.1 Growth Patterns Across Pediatric Age Bands 2.2 Developmental Milestones & Feeding Skill Acquisition
3 Human Milk & Infant Formulas
3.1 Human Milk & Lactation Management 3.2 Milk Handling, Storage, Donor Milk & Fortification 3.3 Infant & Specialized Formulas
4 Age-Appropriate Nutrition & Foods
4.1 Complementary Feeding & Toddler Nutrition 4.2 School-Age & Adolescent Nutrition
5 Prematurity & the NICU Graduate
5.1 Preterm Nutrition in the NICU 5.2 Post-Discharge Nutrition for Preterm Infants
6 Congenital, Developmental & Metabolic Conditions
6.1 Congenital & Neurodevelopmental Conditions 6.2 Inborn Errors of Metabolism
7 GI Disorders & Food Allergy
7.1 Gastrointestinal Disorders: IBD, Celiac, Short Bowel & GERD 7.2 Food Allergy, FPIES & Eosinophilic Esophagitis
8 Body System & Organ Dysfunction
8.1 Cystic Fibrosis & Respiratory Support 8.2 Congenital Heart Disease & Cardiac Conditions 8.3 Chronic Kidney Disease, Dialysis & Transplant
9 Oncology, Endocrine & Weight-Related Care
9.1 Pediatric Oncology & HSCT Nutrition 9.2 Diabetes Management & Ketogenic Diet Therapy 9.3 Pediatric Overweight & Obesity (AAP 2023 Guideline) 9.4 Eating Disorders, ARFID & Pediatric Feeding Disorder
10 Clinical Status & Health History
10.1 Medical Treatment & Medication History 10.2 Nutrition & Supplementation History 10.3 Cultural & Psychosocial Factors 10.4 Activity & Lifestyle History 10.5 Birth, Perinatal & Surgical History
11 Anthropometrics & Growth Assessment
11.1 Anthropometric Measurement Techniques 11.2 Growth Charts & Z-Score Interpretation 11.3 Growth Assessment in Preterm & Special Populations 11.4 Pediatric Malnutrition: AND/ASPEN Consensus Criteria 11.5 Body Composition Assessment in Children
12 Physical Exam, Laboratory Data & Nutrition Diagnosis
12.1 Nutrition-Focused Physical Exam 12.2 Diagnostic & Laboratory Testing 12.3 Micronutrient Status Assessment & Deficiency Workup 12.4 Gastrointestinal Function & Diagnostic Testing 12.5 Nutrition Diagnosis, PES Statements & the NCP
13 Estimation of Nutritional Needs
13.1 Energy Needs Across Age & Clinical State 13.2 Protein & Fluid Requirements 13.3 Micronutrient Needs & Catch-Up Growth 13.4 Estimating Needs in Critical Illness & Special Clinical States
14 Oral Nutrition & Supplementation
14.1 Oral Nutrition & Therapeutic Diet Modification 14.2 Texture Modification & Dysphagia Management 14.3 Vitamin & Mineral Supplementation
15 Enteral Nutrition Support
15.1 Enteral Nutrition: Indications & Access 15.2 Enteral Formula Selection 15.3 Feeding Regimens, Advancement & Complications
16 Parenteral Nutrition Support
16.1 PN Indications & Composition 16.2 PN Initiation, Advancement & Monitoring 16.3 PN Complications & IFALD
17 Care Planning, Coordination & Education
17.1 Monitoring & Evaluation of Nutrition Care 17.2 Interdisciplinary Coordination & Transitions of Care 17.3 Access to Food & Healthcare: Federal Programs 17.4 Education & Counseling for Children & Families 17.5 Documentation, Quality & Outcomes in Pediatric Nutrition Care 17.6 Ethics, Palliative Care & Nutrition Decision-Making
8.3 Chronic Kidney Disease, Dialysis & Transplant
Key Takeaways Explain This Topic AI
Pediatric CKD is staged by GFR (KDIGO G1-G5; G5 is GFR <15 mL/min/1.73 m2), and nutrition goals are to preserve growth and prevent CKD-mineral and bone disorder.
Protein should never fall below the DRI for age in children with CKD — growth takes priority — while energy must be adequate to prevent protein catabolism.
Phosphate binders work only when given with meals and snacks; dietary counseling targets both natural phosphorus and phosphate additives in processed foods.
Peritoneal dialysis adds calories from dialysate glucose absorption and loses protein into the effluent (worse with peritonitis), both of which reshape the prescription.
Infants with CKD nearly always need tube feeding support, and kidney transplant candidacy is typically reached at about 10 kg body weight.
Last updated: August 2026
Staging and Nutrition Goals in Pediatric CKD
Chronic kidney disease (CKD) in children is staged by glomerular filtration rate (GFR) using the KDIGO classification: G1 (>=90), G2 (60-89), G3a (45-59), G3b (30-44), G4 (15-29), and G5 (<15 mL/min/1.73 m2) , with G5 subdivided into G5D when on dialysis. Unlike adults, in whom slowing progression dominates, pediatric nutrition has a dual mandate: preserve linear growth and neurodevelopment while preventing CKD-mineral and bone disorder (CKD-MBD) , cardiovascular calcification, and uremic toxicity.
Protein and Energy
The guiding rule: avoid protein excess but never restrict protein below the Dietary Reference Intake (DRI) for age — inadequate protein costs growth, and growth is the non-negotiable outcome in children. Very high protein intakes are discouraged because they increase solute load and phosphorus intake. Energy must be adequate (generally at the estimated requirement for age, individualized to growth velocity) so that dietary protein is used for synthesis rather than catabolized for fuel ; in infants, feeds are concentrated and tube feeding is used freely to hit energy targets.
Potassium, Sodium, and Fluid
Potassium restriction is introduced as GFR falls and hyperkalemia appears — typically in CKD G4-G5 or with oliguria. Strategies include choosing lower-potassium fruits and vegetables, leaching techniques, and low-potassium infant formulas when needed. Sodium and fluid management is disease-specific : children with salt-wasting tubular disorders (e.g., obstructive uropathy, renal dysplasia) need sodium supplementation and liberal fluid to grow, whereas children with hypertension, edema, or oliguria need sodium and fluid restriction — a classic exam contrast.
CKD-Mineral and Bone Disorder
CKD-MBD is the triad of biochemical abnormalities (rising parathyroid hormone (PTH) and phosphorus, falling calcium and activated vitamin D), bone disease, and vascular calcification. Management pillars:
Phosphorus restriction: limit dairy-heavy and processed foods, with particular attention to phosphate additives in processed meats, colas, and convenience foods, which are nearly 100% absorbed.
Phosphate binders (calcium acetate, sevelamer) must be given with meals and snacks to bind dietary phosphorus in the gut; given between meals they do nothing.
Active vitamin D sterols ( calcitriol or analogs) suppress PTH; nutritional vitamin D deficiency is repleted first.
Monitor PTH, calcium, and phosphorus regularly against age-specific targets; both under- and over-suppression of PTH harm bone.